log in
Print | Back

Lowenstein Sandler LLP

Lowenstein Sandler LLP  

Legal Services | New York, USA

tel: +212 262 6700 | fax: +212 262 7402
1251 Avenue of the Americas | New York | New York | 10020 | USA

Main Contacts

Gary Wingens

Gary M. WingensChairman and Managing Partner

Lowenstein Sandler LLP's Overview

Lowenstein Sandler is a national law firm with approximately 275 lawyers in New York, Palo Alto, New Jersey, Utah, and Washington, D.C.
We have built a reputation for pursuing every matter with creativity and passion. Our lawyers are guided by four core values:
An intense devotion to client service
An entrepreneurial approach to finding solutions
The ability to anticipate rather than just respond to client needs
Strong relationships based on mutual trust with our colleagues, our clients and our community

The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

  • Lawyers Worldwide: 275


Areas of Practice
  • Antitrust & Trade Regulation
  • Appellate
  • Bankruptcy, Financial Reorganization & Creditors' Rights
  • Broker-Dealer
  • Business Divorce
  • Business Litigation
  • Capital Markets & Securities
  • Class Action Litigation
  • Corporate
  • Corporate Governance & Compliance
  • Corporate Investigations & Integrity
  • Debt Financing
  • Derivatives & Structured Products
  • Employee Benefits & Executive Compensation
  • Employment Counseling & Litigation
  • Environmental Litigation
  • FDA Regulatory
  • Fund Formation & Structuring
  • Fund Regulatory & Compliance
  • Global Capital Markets Litigation
  • Insurance Coverage
  • Intellectual Property Litigation
  • Investment Management
  • Life Sciences
  • Litigation
  • Mergers & Acquisitions
  • Mortgage & Structured Finance
  • Patent Counseling & Prosecution
  • Privacy & Cybersecurity
  • Private Equity
  • Products Liability & Specialty Torts
  • Real Estate
  • Securities Litigation
  • Seed Stage Investing & Startups
  • Tax
  • Technology & Media Transactions
  • The Tech Group
  • Trademarks, Copyrights & Trade Secrets
  • Transactions & Advisory Group
  • Trusts & Estates
  • Venture Capital & Tech M&A


Peter Ehrenberg

Peter H. EhrenbergPartner Chair, Corporate Department

David Leit

David LeitPartner

Gary Wingens

Gary M. WingensChairman and Managing Partner


Of Counsel


Dotan Barnea

Dotan BarneaForeign Legal Consultant admitted to the practice of law in Israel New York Bar Admission Pending

Joseph Hendricks

Joseph S. HendricksBar Admission Pending

Manas Kumar

Manas KumarBar Admission Pending

Alanna Sandoval

Alanna SandovalBar Admission Pending


Securing Indemnification and Additional Insurance Coverage Requires Careful Drafting
Lowenstein Sandler LLP, January 2019

Insurance plays a prominent role in all real estate transactions. Stakeholders generally understand that insurance policies must be secured for the leasehold to address property damage and liability claims. However, stakeholders often do not pay attention to the precise contract language used to establish the insurance requirements and address how the waterfall of available insurance coverage will flow. Recently, the New Jersey Appellate Division provided a cautionary tale about the importance of careful drafting as it relates to whether coverage is available and, if so, when it must be provided. In Lopez v. Palin Enterprises, Associated, No. A-0886-17T4 (N.J. App. Div. Dec...

Obstacles to IPOs Faced by Life Sciences Companies
Lowenstein Sandler LLP, October 2018

Initial public offerings (IPOs) are often seen as attractive by business owners in the life sciences or biotech field, writes Alan Wovsaniker, a partner with Lowenstein Sandler, in an Expert View column on the topic. The need for capital in a life sciences business tend to be great, as the cost to develop new drugs, therapies or medical devices is extremely expensive and it takes many years to receive regulatory approval to market and sell such drugs, therapies or medical devices...

All articles submitted by Lowenstein Sandler LLP


Lowenstein Represents DealCloud in Acquisition by Intapp
Lowenstein Sandler LLP, August 2018

Lowenstein Sandler represented client DealCloud in its acquisition by Intapp. DealCloud specializes in CRM and deal management software for investment banking and private equity firms. Intapp is a leading provider of industry solutions for the $2 trillion global professional services industry. According to the companies’ press release, “This acquisition continues Intapp’s mission to create a vertical industry platform for the professional services sector...

Lowenstein Represents Motus GI Holdings, Inc., in $18 Million Medical Technology IPO
Lowenstein Sandler LLP, February 2018

Lowenstein represented medical device company Motus GI Holdings, Inc., in an $18 million IPO involving the sale of 3.5 million shares priced at $5 per share. Shares started trading on February 14, 2018. Piper Jaffray and Oppenheimer & Co. are underwriting the offering. An Israel-based development stage company now operating in the United States, Motus specializes in colonoscopy-related medical technology designed to enhance procedural quality and cost-effectiveness. The company intends to invest the newly generated funds in commercializing its technology...

All press submitted by Lowenstein Sandler LLP


Capital Markets Litigation
Lowenstein Sandler LLP 

Litigation News for the Global Financial Community

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2019